Publications by authors named "Georges Nembot"

Claim this Profile
C
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
Antoine Chéret, Charline Bacchus-Souffan, Veronique Avettand-Fenoël, Adeline Mélard, Georges Nembot

J Antimicrob Chemother· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Antoine Chéret, Georges Nembot, Adeline Mélard, Caroline Lascoux, Laurence Slama

Lancet Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
Camille Lécuroux, Isabelle Girault, Antoine Chéret, Pierre Versmisse, Georges Nembot

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.
Charline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, Georges Nembot, Adeline Mélard

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Jean-Jacques Parienti, Aurélie Barrail-Tran, Xavier Duval, Georges Nembot, Diane Descamps

Antimicrob Agents Chemother· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis